Casi pharmaceuticals announces first quarter 2024 business and financial results

Beijing , may 14, 2024 /prnewswire/ -- casi pharmaceuticals, inc. (nasdaq: casi), a cayman incorporated biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today reported financial results for the three months ended march 31, 2024. in the first quarter of 2024, casi's total revenue was $3.4 million.

CASI Ratings Summary

CASI Quant Ranking